ReviewCancers2022
Robotic-Assisted Surgery for Primary Hepatobiliary Tumors-Possibilities and Limitations.
Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 20 citations in OpenAlex.
- Artificial intelligence in hepatocellular carcinoma diagnosis and AI-assisted treatment support: Current landscape and future directions.Liver research (Beijing, China) · 2026Review
- Robotic versus laparoscopic hepatectomy: an umbrella review of systematic reviews and meta-analyses.Surgery in practice and science · 2026Review
- Comparison of robotic and open liver resections for primary liver tumors: a multicenter retrospective analysis of perioperative outcomes, morbidity and mortality.Surgical endoscopy · 2026Article
- What we missed then, AI sees now: Revisiting legacy large extracellular vesicle data to reveal synergistic biomarkers for liver cancer screening.JHEP reports : innovation in hepatology · 2025Article
- A Decade of Innovation: Short-Term Outcomes of 150 Robotic Liver Resections.Journal of clinical medicine · 2025Article
- Comparing Perioperative Outcomes of Robotic-Assisted Versus Laparoscopic Liver Resection in Patients with Hepatocellular Carcinoma.Journal of Cancer · 2025Article
- Evaluation of the economic impact of the robotic approach in major and postero-superior segment liver resections: a multicenter retrospective analysis.Hepatobiliary surgery and nutrition · 2024Article
- Feasibility, safety and limits of robotic approach for lymphadenectomy in biliary tumours.Hepatobiliary surgery and nutrition · 2023Article
- Development and Clinical Trial of a New Orthopedic Surgical Robot for Positioning and Navigation.Journal of clinical medicine · 2022Article
- Integration of Three-Dimensional Liver Models in a Multimodal Image-Guided Robotic Liver Surgery Cockpit.Life (Basel, Switzerland) · 2022Article
- Global trends and hotspots in research of robotic surgery in oncology: A bibliometric and visual analysis from 2002 to 2021.Frontiers in oncology · 2022Article
- Robotic Resection of Caudate Lobe Hepatocellular Carcinoma.CRSLS : MIS case reports from SLSArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatocellular and cholangiocellular carcinoma are fatal primary hepatic tumors demanding extensive liver resection. Liver surgery is technically challenging due to the complex liver anatomy, with an intensive and variant vascular and biliary system. Therefore, major hepatectomies in particular are often performed by open resection and minor hepatectomies are often performed minimally invasively. More centers have adopted robotic-assisted surgery, intending to improve the laparoscopic surgical limits, as it offers some technical benefits such as seven degrees of freedom and 3D visualization. The da Vinci
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.